Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Consolaro

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Rheumatology (Oxford, England)|February 2, 2021
Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centersGiulia Camilla Varnier, Alessandro Consolaro, Susan Maillard, et al.
Rheumatology International|April 12, 2018
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Cristina Herrera Mora, Stella Maris Garay, Alessandro Consolaro, et al.
Clinical and Experimental Rheumatology|October 17, 2013
Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritisSara Verazza, Giorgia Negro, Denise Marafon, et al.
Neuroimmunomodulation|September 18, 2014
Glucocorticoids in juvenile idiopathic arthritisBenedetta Schiappapietra, Giulia Varnier, Silvia Rosina, et al.
Frontiers in Pharmacology|December 22, 2016
IL-1 Inhibition in Systemic Juvenile Idiopathic ArthritisGabriella Giancane, Francesca Minoia, Sergio Davì, et al.
Rheumatology and Therapy|October 18, 2016
Juvenile Idiopathic Arthritis: Diagnosis and TreatmentGabriella Giancane, Alessandro Consolaro, Stefano Lanni, et al.
Best Practice & Research. Clinical Rheumatology|May 19, 2018
Recent therapeutic advances in juvenile idiopathic arthritisGabriella Giancane, Alessandra Alongi, Silvia Rosina, et al.
The Lancet. Rheumatology|March 2, 2026
Paediatric rheumatology care in Europe: setting children and adolescents into focusDirk Foell, Marija Jelusic, Erdal Sag, et al.
Expert Review of Clinical Immunology|June 18, 2021
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritisSilvia Rosina, Valentina Natoli, Stefania Santaniello, et al.
Rheumatology International|April 12, 2018
The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Zoilo Morel Ayala, Ruben Burgos-Vargas, Alessandro Consolaro, et al.
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Rheumatology (Oxford, England)|February 2, 2021
Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centersGiulia Camilla Varnier, Alessandro Consolaro, Susan Maillard, et al.
Rheumatology International|April 12, 2018
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Cristina Herrera Mora, Stella Maris Garay, Alessandro Consolaro, et al.
Clinical and Experimental Rheumatology|October 17, 2013
Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritisSara Verazza, Giorgia Negro, Denise Marafon, et al.
Neuroimmunomodulation|September 18, 2014
Glucocorticoids in juvenile idiopathic arthritisBenedetta Schiappapietra, Giulia Varnier, Silvia Rosina, et al.
Frontiers in Pharmacology|December 22, 2016
IL-1 Inhibition in Systemic Juvenile Idiopathic ArthritisGabriella Giancane, Francesca Minoia, Sergio Davì, et al.
Rheumatology and Therapy|October 18, 2016
Juvenile Idiopathic Arthritis: Diagnosis and TreatmentGabriella Giancane, Alessandro Consolaro, Stefano Lanni, et al.
Best Practice & Research. Clinical Rheumatology|May 19, 2018
Recent therapeutic advances in juvenile idiopathic arthritisGabriella Giancane, Alessandra Alongi, Silvia Rosina, et al.
The Lancet. Rheumatology|March 2, 2026
Paediatric rheumatology care in Europe: setting children and adolescents into focusDirk Foell, Marija Jelusic, Erdal Sag, et al.
Expert Review of Clinical Immunology|June 18, 2021
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritisSilvia Rosina, Valentina Natoli, Stefania Santaniello, et al.
Rheumatology International|April 12, 2018
The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Zoilo Morel Ayala, Ruben Burgos-Vargas, Alessandro Consolaro, et al.
Pageof 18